ESC Professional Premium Access

Treatment of coronary artery disease

Event: ESC Congress 2022
Topic: Pharmacotherapy
Session type: Moderated ePosters
Date: 29 August 2022
Time: 16:15 - 16:45

Congress Session

6 presentations in this session

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention 12 months after acute myocardial infarction. Results of the prospective GULLIVE-R study.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)
Thumbnail

Infarct size, inflammatory burden and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.

Speaker: Doctor A. Sansonetti (Bologna, IT)
Thumbnail

The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Speaker: Ms E. Woelders (Nijmegen, NL)
Thumbnail

Positive predictive value of the crusade score for bleeding events in patients with acute coronary syndromes on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel

Speaker: Doctor J. Monteiro (Vila Real, PT)
Thumbnail

To pretreat or not no pretreat with dual antiplatelet therapy in non-ST elevation acute coronary syndrome patients: that is the question.

Speaker: Doctor D. Abella Vallina (Burgos, ES)
Thumbnail

Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial

Speaker: Doctor E. Rexhaj (Bern, CH)
Thumbnail

6 speakers from this session

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)
13 presentations
0 follower

Doctor Angelo Sansonetti

S. Orsola-Malpighi Policlinic, Bologna (Italy)
0 follower

Ms Eva Christine Ida Woelders

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Doctor Jose Joao Monteiro

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)
0 follower

Doctor David Abella Vallina

University Hospital of Burgos, Burgos (Spain)
0 follower

Doctor Emrush Rexhaj

University Hospital, Inselspital Bern, Bern (Switzerland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk